ArticleEJNMMI research2024

Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.

Märta Persson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.